View Day Schedule

Wednesday, November 17, 2021 Print Current Day:

SESSION 23 SCHEDULE
Wednesday SESSION 23: GENERALITIES IN THE ENDOVASCULAR AND OPEN TREATMENT OF LOWER EXTREMITY OCCLUSIVE DISEASE AND CLTI (5 AND 4 ¾-MINUTE SHORT SUMMARY [SS] TALKS) Location: Grand Ballroom East, 3rd Floor Moderators:Enrico Ascher, MD / Andrej Schmidt, MD
x
6:40 AM - 6:45 AM	How Do Prior Endovascular Interventions Effect Future Lower Extremity Bypass Outcomes For CLTI
	Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS Location: Grand Ballroom East, 3rd Floor
6:46 AM - 6:51 AM	Do Diabetic Patients With CLTI And Substantial Foot Necrosis Have Time For An Endovascular First Strategy: Why Primary Open Bypass Treatment Is Better
	Presenter(s):Katariina M. Noronen, MD, PhD Location: Grand Ballroom East, 3rd Floor
6:52 AM - 6:57 AM	Statins Decrease Rates Of Mortality, Amputation, MACE And Strokes And Increase Procedural Patency Rates In CLTI Patients: What Is The Best Drug And Dose
	Presenter(s):Richard Bulbulia, MA, MD, FRCS Location: Grand Ballroom East, 3rd Floor
6:58 AM - 7:03 AM	Key New Developments In Endovascular Treatments For CLTI
	Presenter(s):Sahil A. Parikh, MD Location: Grand Ballroom East, 3rd Floor
7:04 AM - 7:09 AM	Small Artery Disease (SAD) Medial Artery Calcification (MAC) And elow The Ankle (BTA) Disease: Major Causes Of CLTI With A Poor Prognosis: How Are They Best Treated Endovascularly
	Presenter(s):Roberto Ferraresi, MD Location: Grand Ballroom East, 3rd Floor
OPTIMAL TECHNIQUES FOR VESSEL PREP FOR ENDOVASCULAR TREATMENTS
7:10 AM - 7:15 AM	[SS] Optimal Different Techniques Of Vessel Prep For Plain Old Balloon Angioplasty (POBA), Drug Coated Balloon (DCB) Treatment And Drug Eluting Stent (DES) Treatment
	Presenter(s):Fabrizio Fanelli, MD, EBIR Location: Grand Ballroom East, 3rd Floor
7:15 AM - 7:20 AM	[SS] Technical Tips For Vessel Prep Before DCBs And DESs: It Is Different And Not Simple
	Presenter(s):Erwin Blessing, MD Location: Grand Ballroom East, 3rd Floor
7:20 AM - 7:25 AM	Thirteen Technical Tips For Safe Radial Access For Renal/Visceral And Lower Extremity Interventions: How Far Distally In The Leg Can Lesions Be Treated
	Presenter(s):Craig M. Walker, MD Location: Grand Ballroom East, 3rd Floor
7:26 AM - 7:31 AM	What Are The Downsides To Trans-Radial Or Pedal Access
	Presenter(s):Gary M. Ansel, MD Location: Grand Ballroom East, 3rd Floor
TECHNICAL TIPS ON GUIDEWIRE CHOICE AND USAGE
7:32 AM - 7:37 AM	[SS] Guidewire Tips For Treating SFA And Popliteal Artery Lesions Including CTOs
	Presenter(s):Marco G. Manzi, MD Location: Grand Ballroom East, 3rd Floor
7:37 AM - 7:42 AM	[SS] Guidewire Tips For Treating BTK And Crural Artery Lesions
	Presenter(s):Craig M. Walker, MD Location: Grand Ballroom East, 3rd Floor
7:42 AM - 7:47 AM	[SS] Guidewire Tips For Treating Lesions Below the Ankle (BTA): Sliding, Piercing, Dissecting, Retrograde Maneuvers
	Presenter(s):Roberto Ferraresi, MD Location: Grand Ballroom East, 3rd Floor
7:47 AM - 7:53 AM	Panel Discussion
END OF SESSION 23

SESSION 24 SCHEDULE
Wednesday SESSION 24: NEW DEVELOPMENTS IN ATHERECTOMY, STENTS (UNCOATED, COATED AND BIORESORBABLE) (ALL TALKS ARE 5 MINUTES) Location: Grand Ballroom East, 3rd Floor Moderators:Craig M. Walker, MD / Iris Baumgartner, MD
x
PROGRESS IN ATHERECTOMY
7:53 AM - 7:58 AM	New Developments In Laser Atherectomy: What Makes It Different: When Is It Beneficial With Certainty
	Presenter(s):George L. Adams, MD Location: Grand Ballroom East, 3rd Floor
7:59 AM - 8:04 AM	Value Of Phoenix Atherectomy And Stellarex DCB For Infrapopliteal Lesions: Why IVUS Guidance Is Beneficial: 1-Yea Results In CLTI Patients
	Presenter(s):Michael K.W. Lichtenberg, MD / Thomas Zeller, MD Location: Grand Ballroom East, 3rd Floor
8:05 AM - 8:10 AM	Optical Coherence Tomography (OCT) Guided Atherectomy (Pantheris) For In Stent Restenosis (ISR): Why It Is More Effective Treatment: From The INSIGHT Trial
	Presenter(s):Todd R. Vogel, MD, MPH Location: Grand Ballroom East, 3rd Floor
8:11 AM - 8:16 AM	Current Role Of Atherectomy In Treating Lower Extremity CLTI: A Vascular Surgeon’s View
	Presenter(s):James F. McKinsey, MD Location: Grand Ballroom East, 3rd Floor
UPDATE ON THE SUPERA STENT
8:17 AM - 8:23 AM	Update On The Advantages Of The Supera Vasculomimetic (VMI) Stent For Treating Long Complex Fempop Occlusive Lesions: Is There Value To DCB Vessel Prep First
	Presenter(s):Peter C.J. Goverde, MD Location: Grand Ballroom East, 3rd Floor
8:23 AM - 8:28 AM	Value And Technical Tips To Make The Supera Stent Work In Curved And Angulated Non-SFA Lesion Locations
	Presenter(s):Rajiv Parakh, MBBS, MS, FRCS Location: Grand Ballroom East, 3rd Floor
DRUG ELUTING STENTS FOR BTK LESIONS
8:29 AM - 8:34 AM	10-Year Experience With Everolimus DESs To Treat Long Infrapopliteal Lesions Causing CLTI: Indications, Results, Value And Limitations
	Presenter(s):Robert A. Lookstein, MD, MHCDL, FSIR, FAHA Location: Grand Ballroom East, 3rd Floor
8:35 AM - 8:40 AM	Bioresorbable Everolimus DESs To Treat BTK Lesions Causing CLTI: Promising Results Up To 5-7 Years: From The DISAPEAR Trial And A Meta-Analysis Of The Absorb Stent From Abbott
	Presenter(s):Steven Kum, MD / Ramon L. Varcoe, MBBS, MS, FRACS, PhD Location: Grand Ballroom East, 3rd Floor
8:41 AM - 8:46 AM	What Is The Future For Bioresorbable DESs To Treat BTK Lesions: Good Long-Term Results Justify A New Trial: The LIFE-BTK Trial With The Esprit Stent From Abbott
	Presenter(s):Ramon L. Varcoe, MBBS, MS, FRACS, PhD / Sahil A. Parikh, MD / Brian G. DeRubertis, MD Location: Grand Ballroom East, 3rd Floor
8:47 AM - 8:52 AM	A 3-French Compatible Microstent (From Micro Medical) For Antegrade Or Retrograde Insertion To Treat Tibial Artery Lesions: The STAND Trial
	Presenter(s):Robert E. Beasley, MD, FSIR, FSCAI Location: Grand Ballroom East, 3rd Floor
8:53 AM - 9:00 AM	Panel Discussion
END OF SESSION 24

SESSION 25 SCHEDULE
Wednesday SESSION 25: LOWER EXTREMITY TOPICS RELATED TO THE DRUG COATED DEVICES CAUSING INCREASED MORTALITY CONTROVERSY: DO PACLITAXEL COATED DEVICES CAUSE INCREASED MORTALITY (5 AND 4 ¾-MINUTE SHORT SUMMARY [SS] TALKS) Location: Grand Ballroom East, 3rd Floor Moderators:Kenneth Ouriel, MD, MBA / Sahil A. Parikh, MD
x
9:00 AM - 9:05 AM	Older And More Recent Meta-Analyses Reveal An Increased Mortality Signal In Patients Receiving Paclitaxel Coated Devices Compared To Uncoated Devices: The More Recent Study Of DCBs In BTK Arteries Showed Increased Mortality And Amputation Rates After Only 1 Year
	Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR Location: Grand Ballroom East, 3rd Floor
9:06 AM - 9:11 AM	How Do Paclitaxel And Limus Drugs Work And Differ In Safety And Effectiveness In Inhibiting Intimal Hyperplasia Induced By Treatment
	Presenter(s):Juan F. Granada, MD Location: Grand Ballroom East, 3rd Floor
9:12 AM - 9:17 AM	Summary Of The Present Status Of The Paclitaxel Mortality Controversy With DCBs And DESs Treatments In The SFA And BTK Arteries
	Presenter(s):Andrew Holden, MBChB Location: Grand Ballroom East, 3rd Floor
9:18 AM - 9:23 AM	Alternatives To Paclitaxel Coated Devices For Limiting Intimal Hyperplasia After Treatment: Sirolimus Coating, Bioresorbables And Advential Drug Delivery With The Bullfrog Device: Is The Paclitaxel Mortality Signal Real
	Presenter(s):William A. Gray, MD Location: Grand Ballroom East, 3rd Floor
9:24 AM - 9:29 AM	Real World Big Data Patient-Level Evidence Confirms No Harm From Paclitaxel Coated Devices For Treating Fempop Disease: Update On Medicare Data From Over 150,000 Patients
	Presenter(s):Eric A. Secemsky, MD, MSc / Robert Yeh, MD Location: Grand Ballroom East, 3rd Floor
9:30 AM - 9:35 AM	Large Population Based German Multicenter Study Of Paclitaxel Coated BTK DCBs And DESs Indicates Decreased Mortality And Amputation Rates Compared To Uncoated Devices
	Presenter(s):Christian A. Behrendt, MD Location: Grand Ballroom East, 3rd Floor
RELEVANT COMMENTS AS SHORT SUMMARY [SS] TOPICS (4 ¾-MINUTE TALKS)
9:36 AM - 9:41 AM	[SS] The Paclitaxel Increased Mortality Effect Reported By Dr. Katsanos et al. Seems Not To Be Confirmed By Added Data
	Presenter(s):Peter A. Schneider, MD Location: Grand Ballroom East, 3rd Floor
9:41 AM - 9:46 AM	[SS] Is The Paclitaxel Increased Mortality Signal Incorrect: The Updated Collected VIVA Data Do Not Confirm It
	Presenter(s):Gary M. Ansel, MD Location: Grand Ballroom East, 3rd Floor
9:46 AM - 9:51 AM	[SS] The Current Japanese View On The Paclitaxel Mortality Signal
	Presenter(s):Osamu Iida, MD Location: Grand Ballroom East, 3rd Floor
9:51 AM - 9:56 AM	[SS] VQI Data Do Not Support The Paclitaxel Increased Mortality Signal
	Presenter(s):Daniel Bertges, MD / Jack L. Cronenwett, MD Location: Grand Ballroom East, 3rd Floor
9:56 AM - 10:01 AM	[SS] Progress And Problems With A Sustained Release Limus DCB: 2-Year Results With The Magic Touch DCB: From The SIRONA Study
	Presenter(s):Dierk Scheinert, MD / Thomas Zeller, MD Location: Grand Ballroom East, 3rd Floor
10:01 AM - 10:08 AM	Panel Discussion
10:08 AM - 10:18 AM	Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 25

SESSION 26 SCHEDULE
Wednesday SESSION 26: NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBs) AND DRUG ELUTING STENTS (DESs): UPDATES ON RANDOMIZED CONTROLLED TRIALS (RCTs) AND BTK LESION TREATMENTS WITH DCBs AND DESs (5-MINUTE TALKS) Location: Grand Ballroom East, 3rd Floor Moderators:Joseph L. Mills, MD / John R. Laird, MD
x
NEW INFORMATION ON DCBs AND DESs FOR FEMPOP LESIONS: UPDATES ON RCTs
10:18 AM - 10:23 AM	Cost Effectiveness Of Drug Eluting Technologies For Femoropopliteal Lesions: They Are Worth The Increased Device Costs
	Presenter(s):Stefan Müller-Hülsbeck, MD Location: Grand Ballroom East, 3rd Floor
10:24 AM - 10:29 AM	Stellarex (Philips) DCBs With Low Dose Paclitaxel Is Safe And Has Higher Patency Rates Than POBA With Fempop Lesions At 4 Years In The ILLUMENATE RCT
	Presenter(s):Sean P. Lyden, MD Location: Grand Ballroom East, 3rd Floor
10:30 AM - 10:35 AM	Pooled Data From The In.Pact RCT DCB Trials For SFA-Pop Lesions Show Safety And Efficacy For 5 Years Compared To POBA: Continued Use Is Justified
	Presenter(s):Peter A. Schneider, MD / John R. Laird, MD Location: Grand Ballroom East, 3rd Floor
10:36 AM - 10:41 AM	New Findings From The DRASTICO Study Comparing DESs To DCBs For Fempop Lesions: 4-Year Results With TASC A/B Lesions Versus TASC C/D Lesions
	Presenter(s):Francesco Liistro, MD Location: Grand Ballroom East, 3rd Floor
10:42 AM - 10:47 AM	Value Of In.Pact DCBs For Long Complex SFA-Pop Lesions Including ISR And CTOs: Technical Tips And Contraindications: From The Global Registry
	Presenter(s):Gunnar Tepe, MD / Marianne Brodmann, MD Location: Grand Ballroom East, 3rd Floor
10:48 AM - 10:53 AM	Update On The Randomized Head To Head Comparison Of In.Pact (Medtronic) And Ranger (Boston Scientific) DCBs For Complex SFA Lesions: 2-Year Results Of The COMPARE RCT: Similar Results With Different Paclitaxel Dosages
	Presenter(s):Dierk Scheinert, MD / Sabine Steiner, MD Location: Grand Ballroom East, 3rd Floor
10:54 AM - 10:59 AM	Update On The Global RANGER II RCT Comparing Ranger DCBs With POBA
	Presenter(s):Marianne Brodmann, MD Location: Grand Ballroom East, 3rd Floor
11:00 AM - 11:05 AM	New Information On The Safety And Effectiveness Of The Cook Zilver PTX DES Based On Global Trials Including A RCT: When Is It The Best Treatment
	Presenter(s):Michael D. Dake, MD Location: Grand Ballroom East, 3rd Floor
11:06 AM - 11:11 AM	3-Year Results Of The IMPERIAL RCT Head To Head Comparison Of The Zilver PTX DES (Cook) With The Eluvia DES (Boston Scientific): Both Are Safe And Effective: Is There A Difference
	Presenter(s):William A. Gray, MD / Stefan Müller-Hülsbeck, MD / Thomas Zeller, MD Location: Grand Ballroom East, 3rd Floor
11:12 AM - 11:18 AM	Panel Discussion
NEW INFORMATION ON BTK DCBs AND DESs
11:18 AM - 11:23 AM	Advances In BTK Drug Delivery Technology And DCBs: What Have We Learned From The In.Pact Deep BTK DCB Trial And Challenges With Treating CLTI Patients
	Presenter(s):Thomas Zeller, MD Location: Grand Ballroom East, 3rd Floor
11:24 AM - 11:29 AM	1-Year Results Of The Lutonix 0.14 DCB (Becton Dickinson) RCT Versus POBA Mostly For CLTI: DCB Has Equal Safety But 6-Month Patency Advantage Not Present At 1 Year
	Presenter(s):Patrick J. Geraghty, MD / Jihad A. Mustapha, MD / Marianne Brodmann, MD / William A. Gray, MD / Dierk Scheinert, MD Location: Grand Ballroom East, 3rd Floor
11:30 AM - 11:35 AM	2-Year Results Of Global Registry Of Lutonix BTK DCBs Mostly For CLTI Show Safety And Reasonable Effectiveness
	Presenter(s):Dierk Scheinert, MD / Michael K.W. Lichtenberg, MD Location: Grand Ballroom East, 3rd Floor
11:36 AM - 11:41 AM	1-Year Results From The AcoArt II BTK DCB RCT Show Safety (No Increased Mortality) And Improved Patency Versus POBA
	Presenter(s):Wei Guo, MD / Francesco Liistro, MD Location: Grand Ballroom East, 3rd Floor
11:42 AM - 11:47 AM	Why BTK DCB Trials Do Not Show Uniformly Better Results: Technical Factors Matter
	Presenter(s):Francesco Liistro, MD Location: Grand Ballroom East, 3rd Floor
11:48 AM - 11:53 AM	Update On The SAVAL Trial With A Self-Expanding DES (From Boston Scientific) For BTK Occlusive Lesions
	Presenter(s):Jihad A. Mustapha, MD / Miguel F. Montero-Baker, MD Location: Grand Ballroom East, 3rd Floor
11:54 AM - 12:00 PM	Panel Discussion
12:00 PM - 1:00 PM	Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 26

SESSION 27 SCHEDULE
Wednesday SESSION 27: PROGRESS IN EXOTIC AND EXTREME NEW TREATMENTS FOR VERY DISTAL LOWER EXTREMITY DISEASE CAUSING ADVANCED CLTI: HOW TO SAVE THE “NO OPTION FOR TREATMENT” LIMB OR THE “DESERT FOOT” WITH NO PATENT TARGET ARTERIES Location: Grand Ballroom East, 3rd Floor Moderators:Daniel G. Clair, MD / Marco G. Manzi, MD
x
1:00 PM - 1:05 PM	No Option CLTI: What Is It: What Are The Actual Options For Treatment
	Presenter(s):Hisham Rashid, FRCS, FRCS(Gen) Location: Grand Ballroom East, 3rd Floor
1:06 PM - 1:11 PM	Contemporary Survival After Below-Knee Amputation (BKA), Above-Knee Amputation (AKA), Bilateral Amputations For Trauma; For Vascular Disease: It Is Worthwhile Saving Limbs Especially In Vascular Patients
	Presenter(s):Philip P. Goodney, MD, MS Location: Grand Ballroom East, 3rd Floor
VALUE OF PROSTHETIC (PTFE) TIBIAL BYPASSES
1:12 PM - 1:17 PM	Value Of Spliced Vein Grafts Versus PTFE Grafts For Bypasses: When A Single Autologous Vein Is Inadequate
	Presenter(s):Joseph L. Mills, MD Location: Grand Ballroom East, 3rd Floor
1:18 PM - 1:23 PM	PTFE Tibial And Peroneal Artery Bypasses Can Save No Option Limbs Which Would Otherwise Require Amputation: They Can Have Long-Term Patency And Limb Salvage And Are Worthwhile
	Presenter(s):Gregg S. Landis, MD / Richard F. Neville, MD / Neal S. Cayne, MD / Nicholas J. Gargiulo III, MD, RPVI, RVT, RDMS, FACS / Frank J. Veith, MD Location: Grand Ballroom East, 3rd Floor
1:24 PM - 1:29 PM	For Patients Facing Amputation With No Endo Options Or Useable Vein, PTFE Tibial Bypasses Are A Worthwhile Option
	Presenter(s):R. Clement Darling III, MD Location: Grand Ballroom East, 3rd Floor
1:30 PM - 1:35 PM	Current Outcomes With PTFE Bypasses To Infrapopliteal (Tibial) Targets: Is There Variability Between Surgeons And Institutions
	Presenter(s):Matthew T. Menard, MD Location: Grand Ballroom East, 3rd Floor
UPDATE ON FOOT VEIN ARTERIALIZATION FOR CLTI
1:36 PM - 1:41 PM	What Is The Real Prevalence Of No Option Anatomy Among The CLTI Population: What Is The Role For Foot Vein Arterialization: How Is It Best Done
	Presenter(s):Peter A. Schneider, MD Location: Grand Ballroom East, 3rd Floor
1:42 PM - 1:47 PM	Role And Value Of Vein Arterialization: Best Way To Do It And Long-Term Results: From The Pioneer
	Presenter(s):Pramook Mutirangura, FRCS (Edinburgh) Location: Grand Ballroom East, 3rd Floor
1:48 PM - 1:53 PM	Pathophysiology Of Venous Arterialization And Neo Angiogenesis For No Option CLTI: How To Predict When It Will Work And When It Won’t
	Presenter(s):Roberto Ferraresi, MD Location: Grand Ballroom East, 3rd Floor
1:54 PM - 1:59 PM	2-Year Registry Results With Deep Vein Arterialization With The LimFlow Device For CLTI With Gangrene Shows Reasonable Limb Salvage And Wound Healing
	Presenter(s):Andrej Schmidt, MD Location: Grand Ballroom East, 3rd Floor
2:00 PM - 2:05 PM	How To Perform The LimFlow Procedure: Equipment Required And Technical Tips
	Presenter(s):Miguel F. Montero-Baker, MD Location: Grand Ballroom East, 3rd Floor
2:06 PM - 2:11 PM	Deep Vein Arterialization And Valve Lysis By Surgical Means For No Option Desert Feet With Gangrene: How To Do It And Results
	Presenter(s):Richard F. Neville, MD Location: Grand Ballroom East, 3rd Floor
2:12 PM - 2:18 PM	Panel Discussion
END OF SESSION 27

SESSION 28 SCHEDULE
Wednesday SESSION 28: NEW DEVELOPMENTS IN STENTS; PROSTHETIC GRAFTS; ENDOVASCULAR BYPASSES; STENT GRAFTS AND TREATMENT OF IN STENT RESTENOSIS (ISR) Location: Grand Ballroom East, 3rd Floor Moderators:Glenn Jacobowitz, MD / Mark A. Adelman, MD
x
2:18 PM - 2:23 PM	3-Year Results From The BioMimics 3D Swirling Flow Stent In The MIMICS-2 Study: Who Needs Paclitaxel
	Presenter(s):Peter Gaines, MD / Michael K.W. Lichtenberg, MD / Timothy M. Sullivan, MD Location: Grand Ballroom East, 3rd Floor
ARTERIAL PTFE BYPASSES
2:24 PM - 2:29 PM	RCT Comparing Heparin Bonded PTFE (Propaten) Grafts With Plain PTFE Grafts For BTK CLTI Bypasses: Is Heparin Bonding Helpful
	Presenter(s):Yann Gouëffic, MD, PhD Location: Grand Ballroom East, 3rd Floor
2:30 PM - 2:35 PM	Hybrid Fluoroscopically Guided Improved Method For Restoring Patency To Occluded PTFE Bypasses: It’s Less Invasive And More Effective
	Presenter(s):Neal S. Cayne, MD / Frank J. Veith, MD Location: Grand Ballroom East, 3rd Floor
PERCUTANEOUS BYPASSES
2:36 PM - 2:41 PM	Percutaneous (PQ) Tranvenous Fempop PTFE Bypasses With The Torus 2 Device: How It Works And Status Of The DETOUR And TORUS Trials In The US And Europe
	Presenter(s):Ehrin Armstrong, MD / Daniel G. Clair, MD / Peter A. Schneider, MD Location: Grand Ballroom East, 3rd Floor
2:42 PM - 2:47 PM	3-Year Results Of The Detour PQ Fempop Arterial Bypass Routed Through The Femoral Vein: Will It Make Open Bypass Obsolete
	Presenter(s):Dainis K. Krievins, MD Location: Grand Ballroom East, 3rd Floor
2:48 PM - 2:53 PM	A Novel Technique For PQ Fempop Bypass Routing The PTFE Bypass Through The Soft Tissue Of The Thigh: How To Do It And Early Results
	Presenter(s):Pierre Saradon, MD / Jean-Pierre Becquemin, MD, FRCS Location: Grand Ballroom East, 3rd Floor
2:54 PM - 2:58 PM	Panel Discussion
NEW INFORMATION ON STENT-GRAFTS
2:58 PM - 3:03 PM	2-Year Results Of The SUPER B RCT Shows That Viabahn Stent-Grafts Have Patency Rates As Good As Open Fempop PTFE Bypasses But Require More Reinterventions: How To Make Viabahns Work Best
	Presenter(s):Michel M.P. Reijnen, MD, PhD Location: Grand Ballroom East, 3rd Floor
3:04 PM - 3:09 PM	Advantages And Limitations Of The Gore Viabahn VBX Balloon Expandable (BE) Covered Stent For Treating Complex SFA Disease: Comparison With The Self-Expanding Viabahn: 1-Year Results From The IVORY Japanese Trial
	Presenter(s):Osamu Iida, MD Location: Grand Ballroom East, 3rd Floor
3:10 PM - 3:15 PM	Advantages, Limitations And Results Of Gore VBX BE Stent-Graft For Occlusive Disease In Various Vascular Beds And For F/B/EVAR Branches: Comparison With Other Stent-Grafts
	Presenter(s):Rocco Giudice, MD / Ciro Ferrer, MD, PhD Location: Grand Ballroom East, 3rd Floor
TREATMENT OF IN STENT RESTENOSIS (ISR)
3:16 PM - 3:02 PM	How Best To Treat Long Difficult ISR In Complex SFA Lesions
	Presenter(s):Sonia Ronchey, MD,PhD Location: Grand Ballroom East, 3rd Floor
3:22 PM - 3:27 PM	The Excimer Laser For Treating ISR: It Has A Role In Grossing And Debulking Difficult Lesions: Technical Tips
	Presenter(s):Craig M. Walker, MD Location: Grand Ballroom East, 3rd Floor
3:28 PM - 3:33 PM	Laser Atherectomy May Facilitate Endovascular Treatment Of ISR But Does Not Provide Long-Term Benefit: How Should ISR Be Treated
	Presenter(s):Russell H. Samson, MD, RVT, FACS Location: Grand Ballroom East, 3rd Floor
3:34 PM - 3:48 PM	Panel Discussion And Break Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 28

SESSION 29 SCHEDULE
Wednesday SESSION 29: LOWER EXTREMITY TRIALS; GUIDELINES; FOOT PERFUSION EVALUATION METHODS AND VALUE OF ANGIOSOMES Location: Grand Ballroom East, 3rd Floor Moderators:Mark K. Eskandari, MD / Gregg S. Landis, MD
x
3:48 PM - 3:53 PM	Update On The BEST-CLI RCT Comparing Endovascular And Open Treatment Of Lower Extremity Ischemia: Current Status, Challenges And What Will Be Its Value
	Presenter(s):Alik Farber, MD, MBA / Matthew T. Menard, MD / Kenneth Rosenfield, MD Location: Grand Ballroom East, 3rd Floor
3:54 PM - 3:59 PM	The Japanese SPINACH Registry Shows Why WIFI Wound Severity Helps To Select Open Versus Endovascular Treatment And Predicts Patient Survival
	Presenter(s):Nobuyoshi Azuma, MD Location: Grand Ballroom East, 3rd Floor
4:00 PM - 4:05 PM	The New Global Vascular Guidelines For CLTI Are Better Than Obsolete TASC Guidelines Because Treatment Recommendations, Revascularization Strategies And Needs For The Future Are Not Based On Lesion Anatomy But Are Nuanced By Other Factors
	Presenter(s):Michael S. Conte, MD Location: Grand Ballroom East, 3rd Floor
METHODS FOR EVALUATING FOOT PERFUSION
4:06 PM - 4:11 PM	Measuring Foot Perfusion After Endo Treatments For CLTI With Perfusion Angiography And Smart Software: Why It Is Important And How To Do It
	Presenter(s):Jim Reekers, MD, PhD Location: Grand Ballroom East, 3rd Floor
4:12 PM - 4:17 PM	Indocyanine Green Fluorescence (IGC-FL) Is A Good Way To Measure Foot Perfusion After Treatment: How It Explains Why The Angiosome Concept Is Important After Endo Treatments But Not After Bypasses
	Presenter(s):Maarit Venermo, MD, PhD Location: Grand Ballroom East, 3rd Floor
4:18 PM - 4:23 PM	How And Why To Measure Foot Perfusion During Endo Treatments: Hyperspectral Imaging, O₂ Sensors, Etc: When Is The Angiosome Concept Helpful; When Not
	Presenter(s):Marianne Brodmann, MD Location: Grand Ballroom East, 3rd Floor
4:24 PM - 4:29 PM	What Are The Best Ways To Evaluate CLTI Treatment Outcomes: Physiology, Wound Healing, Anatomy (Angiography Or Ultrasound), MACE Or MALE: Why It Matters
	Presenter(s):Ido Weinberg, MD, MSc Location: Grand Ballroom East, 3rd Floor
4:30 PM - 4:35 PM	Pedal Arch Patency Is Key To Predicting Limb Salvage With Endovascular Treatment For CLTI With Tissue Necrosis: How Is It Best Evaluated
	Presenter(s):Hasan H. Dosluoglu, MD / Linda Harris, MD Location: Grand Ballroom East, 3rd Floor
4:36 PM - 4:41 PM	Foot Perfusion Measurements Show Why Open Bypasses Are Better Than Endovascular Treatments For CLTI
	Presenter(s):Werner Lang, MD Location: Grand Ballroom East, 3rd Floor
4:42 PM - 4:48 PM	Panel Discussion
END OF SESSION 29

SESSION 30 SCHEDULE
Wednesday SESSION 30: NEW DEVELOPMENTS IN THE TREATMENT OF INTERMITTENT CLAUDICATION AND ACUTE LIMB ISCHEMIA Location: Grand Ballroom East, 3rd Floor Moderators:Michael S. Conte, MD / Matthew T. Menard, MD
x
INTERMITTENT CLAUDICATION (IC)
4:48 PM - 4:53 PM	DEBATE: A RCT After 2 Years Shows That Stent Treatment For Intermittent Claudication (IC) Improves Quality Of Life More Than Medical Treatment And Exercise
	Presenter(s):Hans Lindgren, MD, PhD Location: Grand Ballroom East, 3rd Floor
4:54 PM - 5:00 PM	DEBATE: Interventions For IC Are Safe But Lead To Greater Decreased Function And Increased Limb Loss
	Presenter(s):Jeffrey J. Siracuse, MD Location: Grand Ballroom East, 3rd Floor
5:00 PM - 5:05 PM	Overuse Of Vascular Interventions For IC Is A Measure Of Poor Care: How Is This Determined
	Presenter(s):Caitlin W. Hicks, MD, MS / James H. Black, III, MD Location: Grand Ballroom East, 3rd Floor
5:06 PM - 5:11 PM	Value Of Neuromuscular Electrical Stimulation (NMES) To Treat IC: It Works And How
	Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh, F Location: Grand Ballroom East, 3rd Floor
5:12 PM - 5:16 PM	Panel Discussion
ACUTE LIMB ISCHEMIA (ALI) (SEE ALSO SESSION 63)
5:16 PM - 5:21 PM	Key Points From The New European Guidelines For Diagnosis And Treatment Of ALI In The Upper And Lower Limbs: When To Use Which Treatments
	Presenter(s):Martin Bjorck, MD, PhD Location: Grand Ballroom East, 3rd Floor
5:22 PM - 5:27 PM	Update On Thrombosuction Devices For Treating ALI: Which Device In Which Circumstance: Advantages And Limitations
	Presenter(s):Athanasios Katsargyris, MD / Eric L.G. Verhoeven, MD, PhD Location: Grand Ballroom East, 3rd Floor
5:28 PM - 5:33 PM	Endovascular Mechanical Thrombectomy Is Obviating The Need For Thrombolytics In ALI: Which Device Is Best When And Why
	Presenter(s):Patrick E. Muck, MD, FACS Location: Grand Ballroom East, 3rd Floor
5:34 PM - 5:39 PM	Aspiration Thrombectomy Devices And Techniques For ALI: Are Thrombolytics And Fogarty Balloon Catheters Obsolete
	Presenter(s):Maria A. Ruffino, MD, EBIR Location: Grand Ballroom East, 3rd Floor
5:40 PM - 5:45 PM	Penumbra Indigo Clot Aspiration System To Treat ALI: Why Is It A Game Changer: Technical Tips For Usage
	Presenter(s):James F. Benenati, MD Location: Grand Ballroom East, 3rd Floor
5:46 PM - 5:51 PM	Value And Technical Tips For Using The Indigo Clot Removal System Before Treating ISR And Other Lesions With Balloon And Stents
	Presenter(s):Frank R. Arko, MD Location: Grand Ballroom East, 3rd Floor
5:52 PM - 5:57 PM	How To Treat ALI Under Duplex Ultrasound Guidance: Advantages And Limitations
	Presenter(s):Natalie A. Marks, MD, RPVI, RVT, FSVM / Enrico Ascher, MD Location: Grand Ballroom East, 3rd Floor
5:58 PM - 6:02 PM	Panel Discussion End of Program D
END OF SESSION 30

SESSION 31 SCHEDULE
Wednesday SESSION 31: ADVANCES IN MEDICAL TREATMENTS, NEW ANTI-ATHEROGENIC DRUGS, VALUE OF RIVAROXABAN AND PREVENTING MIs IN VASCULAR SURGERY PATIENTS Location: Grand Ballroom West, 3rd Floor Moderators:Caron B. Rockman, MD / Ido Weinberg, MD, MSc
x
6:40 AM - 6:45 AM	What Adequate And Ideal Lipid Levels Should We Strive For In PAD Patients: How To Get There
	Presenter(s):Marianne Brodmann, MD Location: Grand Ballroom West, 3rd Floor
6:46 AM - 6:51 AM	When, Why And How To Lower High Triglyceride Levels: Value Of Vascepa To Decrease Cardiac Risk In Vascular Patients: Based On The REDUCE-IT RCT
	Presenter(s):Jeffrey S. Berger, MD, MS, FAHA, FACC Location: Grand Ballroom West, 3rd Floor
6:52 AM - 6:57 AM	Risks And Consequences Of Perioperative Myocardial Infarctions (MIs) In Open Vascular Surgery Patients: What Can Be Done To Decrease MI Incidence And Their Morbidity And Mortality When They Occur
	Presenter(s):Peter Henke, MD Location: Grand Ballroom West, 3rd Floor
6:58 AM - 7:03 AM	Update On LDL-C Lowering During A Lifetime: How Low To Strive For; How Young To Start If High; How Old To Continue Statins
	Presenter(s):J. David Spence, MD Location: Grand Ballroom West, 3rd Floor
7:04 AM - 7:09 AM	DEBATE: LDL-C Lowering And Statins For Prophylaxis Of Vascular Events Are Dangerous And Not Helpful
	Presenter(s):Sherif A.H. Sultan, MD, FRCS, EBQS-VASC Location: Grand Ballroom West, 3rd Floor
7:10 AM - 7:15 AM	DEBATE: Not So: LDL-C Lowering With Statins And Other Drugs Stabilizes And Shrinks Plaques And Decreases Morbid Vascular Events: Stopping Statins Increases Patients’ Risk Of MI And Death
	Presenter(s):Ron Waksman, MD Location: Grand Ballroom West, 3rd Floor
7:16 AM - 7:21 AM	Low Dose Rivaroxaban (Bayer) And Aspirin Improve Survival And Decrease Major Adverse Limb Events (MALE) After Endo and Open Treatments For PAD/CLTI: From The VOYAGER RCT
	Presenter(s):Sebastian E. Debus, MD, PhD / Marianne Brodmann, MD Location: Grand Ballroom West, 3rd Floor
7:22 AM - 7:27 AM	How Does The Morbidity And Pathology Of Adverse Events With Arteriosclerosis Depend On Thrombosis: This Explains The Benefits Of Rivaroxaban And Aspirin Seen In The VOYAGER And Compass Trials
	Presenter(s):Anthony J. Comerota, MD, FACS, FACC Location: Grand Ballroom West, 3rd Floor
7:28 AM - 7:33 AM	New Adjunctive Drugs (Plus Statins) To Lower LDL-Cholesterol (LDL-C) In Vascular Patients: Inclisiran, Bempedoic Acid And Ezetimbe: How Do They Work And When And How To Use Them: Level Of LDL-C To Strive For
	Presenter(s):Richard Bulbulia, MA, MD, FRCS Location: Grand Ballroom West, 3rd Floor
7:34 AM - 7:42 AM	Panel Discussion
END OF SESSION 31

SESSION 32 SCHEDULE
Wednesday SESSION 32: CATHETER BASED TREATMENTS OF RESISTANT HYPERTENSION; MANAGEMENT OF CARDIAC PROBLEMS, SMOKING AND TRANSFUSION IN VASCULAR SURGERY PATIENTS; MORTALITY RISK IN STROKE PATIENTS; VASCULAR AND CARDIAC COMPLICATIONS OF COVID-19 Location: Grand Ballroom West, 3rd Floor Moderators:Ron Waksman, MD / Michael R. Jaff, DO
x
UPDATE ON RENAL DENERVATION FOR HYPERTENSION
7:42 AM - 7:47 AM	Current Status Of Renal Denervation For Drug Resistant Hypertension: Why The Simplicity Spyral Radiofrequency Denervation System Is Different: Status Of The SPYRAL HTN-OFF MED RCT (Versus Sham)
	Presenter(s):Sahil A. Parikh, MD Location: Grand Ballroom West, 3rd Floor
7:48 AM - 7:53 AM	Updates On Other Methods Of Renal Denervation: Chemical (Alcohol) Infusion Via The Peregrine Catheter (Ablative Solutions) And Ultrasound Via The Paradise Catheter (ReCor Medical)
	Presenter(s):Horst Sievert, MD Location: Grand Ballroom West, 3rd Floor
7:54 AM - 7:59 AM	Preop Cardiac Evaluation With CT-Based Fractional Flow Reserve (FFRCT) And Selective Coronary Revascularization Saves Lives In Patients Undergoing Procedures For CLTI And Carotid Disease
	Presenter(s):Christopher K. Zarins, MD / Dainis K. Krievins, MD Location: Grand Ballroom West, 3rd Floor
8:00 AM - 8:05 AM	The ISCHEMIA RCT Shows No Difference In Survival For Best Medical Treatment Versus Intervention In Patients With Stable Angina And Moderate Coronary Disease – Although Quality Of Life Is Better After Intervention: Will The Trial Change Practice
	Presenter(s):Judith S. Hochman, MD Location: Grand Ballroom West, 3rd Floor
8:06 AM - 8:11 AM	How And Why Do Thoracic Stent-Grafts For TEVAR Negatively Affect The Heart
	Presenter(s):Frans L. Moll, MD, PhD Location: Grand Ballroom West, 3rd Floor
8:12 AM - 8:17 AM	When Should Smoking Be Stopped Before AAA Repair; Before Lower Extremity Bypass: At Least 4 Weeks Because Duration Of Cessation Matters
	Presenter(s):Jeffrey J. Siracuse, MD Location: Grand Ballroom West, 3rd Floor
8:18 AM - 8:23 AM	Permissive Transfusion Strategies Increase Mortality And Serious Adverse Events After Major Vascular And General Surgery Operative Interventions
	Presenter(s):Panos Kougias, MD, MSc Location: Grand Ballroom West, 3rd Floor
8:25 AM - 8:29 AM	How To Quantitate Late Mortality Risk In Asymptomatic Carotid Stenosis (ACS) Patients: Why It’s Important In Decision Making And What To Do About It Other Than Treating ACS Patients Non-Invasively
	Presenter(s):Andrew N. Nicolaides, MS, FRCS Location: Grand Ballroom West, 3rd Floor
8:30 AM - 8:35 AM	Vascular Complications Of COVID-19 Infections: What Is Known And Unknown: How To Diagnose And Treat
	Presenter(s):Michael E. Barfield, MD Location: Grand Ballroom West, 3rd Floor
8:36 AM - 8:41 AM	Cardiac Complications Of COVID-19 Infections: What Is Their Genesis: Diagnosis And Treatment
	Presenter(s):Roxana Mehran, MD Location: Grand Ballroom West, 3rd Floor
8:42 AM - 8:50 AM	Panel Discussion
8:50 AM - 9:06 AM	Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 32

SESSION 33 SCHEDULE
Wednesday SESSION 33: PROGRESS IN MANAGING ENDOLEAKS: UNDERSTANDING THEIR CONSEQUENCES AND PREDICTING, PREVENTING AND TREATING THEM Location: Grand Ballroom West, 3rd Floor Moderators:Timur P. Sarac, MD / Michel Makaroun, MD
x
TO TREAT OR NOT TO TREAT TYPE 2 ENDOLEAKS
9:06 AM - 9:11 AM	Most Type 2 Endoleaks Are Benign: The Case Can Be Made That By Treating Type 2 Endoleaks The Harm And Cost Of Such Treatment Outweighs The Benefits: When If Ever Should They Be Treated
	Presenter(s):Michel M.P. Reijnen, MD, PhD Location: Grand Ballroom West, 3rd Floor
TREATING TYPE 1 ENDOLEAKS
9:12 AM - 9:17 AM	Type 1A Endoleaks After EVAR Are Predictable And Preventable: How To Do So
	Presenter(s):Michael J. Singh, MD Location: Grand Ballroom West, 3rd Floor
9:18 AM - 9:23 AM	When And How To Treat Type 1 Endoleaks With Embolization: Technical Tips
	Presenter(s):Robert A. Morgan, MD Location: Grand Ballroom West, 3rd Floor
9:24 AM - 9:29 AM	When And How To Use Embolization Coils To Treat Type 1A Endoleaks Successfully: When Won’t Coils Work: How To Diagnose Type 1A Endoleaks Accurately
	Presenter(s):Sigrid Nikol, MD Location: Grand Ballroom West, 3rd Floor
9:30 AM - 9:35 AM	How To Minimize Gutter Type 1A Endoleaks With Chimney EVAR (Ch/EVAR): How To Treat Them When They Occur: When Not To Treat Them
	Presenter(s):Konstantinos P. Donas, MD Location: Grand Ballroom West, 3rd Floor
9:36 AM - 9:41 AM	Fibrin Glue Sac Filling Technique During EVAR To Prevent All Endoleaks: It Should Be Routine And Is A Game Changer Based On A Multicenter Trial: How To Do It
	Presenter(s):Qingsheng Lu, MD Location: Grand Ballroom West, 3rd Floor
ROLE OF INFLAMMATION
9:42 AM - 9:47 AM	The Role Of Inflammation In Causing Late Endoleaks: How To Evaluate It And How Should It Influence Treatment
	Presenter(s):Furuzan Numan, MD Location: Grand Ballroom West, 3rd Floor
9:48 AM - 9:53 AM	Panel Discussion
PREVENTION OF TYPE 2 ENDOLEAKS AFTER EVAR
9:53 AM - 9:58 AM	A RCT Shows The Advantages Of Inferior Mesenteric Artery (IMA) And Lumbar Embolization: Confirmed By A Japanese RCT: When And How To Do It
	Presenter(s):Dominique Fabre, MD, PhD / Stephan Haulon, MD Location: Grand Ballroom West, 3rd Floor
9:59 AM - 10:04 AM	Preventing Threatening Type 2 Endoleaks By IMA Embolization When AAA Sac And IMA Are Large: Indications And Technical Tips And Evidence
	Presenter(s):Toru Kuratani, MD, PhD Location: Grand Ballroom West, 3rd Floor
10:05 AM - 10:10 AM	With A Large IMA (> 3mm), When Should It Be Embolized; When Should It Be Revascularized And Why
	Presenter(s):Piotr M. Kasprzak, MD Location: Grand Ballroom West, 3rd Floor
10:11 AM - 10:16 AM	Selective Coiling Of IMA And Lumbar Arteries Decrease Harmful Type 2 Endoleaks: When And How To Do It
	Presenter(s):Götz M. Richter, MD, PhD Location: Grand Ballroom West, 3rd Floor
10:17 AM - 10:22 AM	Panel Discussion
TREATMENT OF TYPE 2 ENDOLEAKS AFTER EVAR
10:22 AM - 10:27 AM	How Duplex Ultrasound Velocities In Type 2 Endoleaks Determine Behavior And Help In Treatment: Technical Tips
	Presenter(s):Ross Milner, MD Location: Grand Ballroom West, 3rd Floor
10:28 AM - 10:33 AM	Glue Embolization Is Effective Treatment For Most Threatening Type 2 Endoleaks: When And How Best To Do It
	Presenter(s):Neal S. Cayne, MD Location: Grand Ballroom West, 3rd Floor
10:34 AM - 10:39 AM	Transcaval Access To AAA Sacs For Treatment Of Type 2 Endoleaks After EVAR: When And How To Do It
	Presenter(s):Adam Beck, MD Location: Grand Ballroom West, 3rd Floor
10:40 AM - 10:45 AM	How To Best Leverage 3D Fusion Software (GE) To Get Into The Nidus And Treat Type 2 Endoleaks: Best Embolic Agent And Value Of Transcaval Access
	Presenter(s):Mark W. Mewissen, MD, RVT Location: Grand Ballroom West, 3rd Floor
10:46 AM - 10:51 AM	Transgraft Approach To Treat Type 2 Endoleaks: Indications, Equipment, Advantages And Precautions
	Presenter(s):James F. McKinsey, MD Location: Grand Ballroom West, 3rd Floor
10:52 AM - 10:57 AM	Laser Assisted Transgraft Onyx Embolization Of Type 2 Endoleaks: Indications, Equipment And Technique
	Presenter(s):Zvonimir Krajcer, MD, FACC Location: Grand Ballroom West, 3rd Floor
10:58 AM - 11:03 AM	With Type 2 Endoleaks And Sac Expansion Open Sacotomy And Branch Ligation Is The Best Treatment: Why And What Precautions Are Needed To Be Sure There Is Not Occult Type 1 Leak
	Presenter(s):Zachary M. Arthurs, MD Location: Grand Ballroom West, 3rd Floor
11:04 AM - 11:12 AM	Panel Discussion
END OF SESSION 33

SESSION 34 SCHEDULE
Wednesday SESSION 34: TCT RECORDED LIVE COMPLEX AND CHALLENGING ENDOVASCULAR CASES Location: Grand Ballroom West, 3rd Floor Moderators:Juan F. Granada, MD / Sahil A. Parikh, MD
x
11:12 AM - 12:00 PM	PROGRAM TO BE DETERMINED
END OF SESSION 34

SESSION 35 SCHEDULE
Wednesday SESSION 35: VIDEO SESSION: RECORDED LIVE CHALLENGING ENDOVASCULAR CASES AND INNOVATIVE TECHNIQUES Location: Grand Ballroom West, 3rd Floor Moderators:TBD
x
PART 1 – PLINIO ROSSI’S RECORDED LIVE CASE SESSION
Moderator(s): Fabrizio Fanelli, MD, EBIR / Andrew Holden, MBChB / Carlo Setacci, MD
1:00 PM - 1:25 PM	PROGRAM TO BE DETERMINED
PART 2 – RECORDED LIVE CASES FROM LINC AND LEIPZIG
Moderator(s): Dierk Scheinert, MD / Giancarlo Biamino, MD, PhD / Andrej Schmidt, MD
1:25 PM - 1:50 PM	PROGRAM TO BE DETERMINED
END OF SESSION 35

SESSION 36 SCHEDULE
Wednesday SESSION 36: ISSUES IMPORTANT TO HISTORY, VASCULAR SURGICAL LEADERSHIP, SCIENCE, TRAINING AND CAREERS Location: Grand Ballroom West, 3rd Floor Moderators:Kim J. Hodgson, MD / Bruce A. Perler, MD, MBA
x
HISTORICAL NOTE
1:50 PM - 1:55 PM	What Vascular Injury Killed Martin Luther King, Jr. And Why He Might Have Survived Today
	Presenter(s):Cynthia K. Shortell, MD Location: Grand Ballroom West, 3rd Floor
1:56 PM - 2:01 PM	How To Succeed In Academic Vascular Surgery: Don’t Be A Revolutionary
	Presenter(s):Ronald L. Dalman, MD Location: Grand Ballroom West, 3rd Floor
2:02 PM - 2:07 PM	How To Become President Of A Major Vascular Society Or The SVS
	Presenter(s):Anil P. Hingorani, MD Location: Grand Ballroom West, 3rd Floor
2:08 PM - 2:13 PM	Vascular Surgery In The Democratic Republic Of The Congo: An Amazing Story
	Presenter(s):Jesse M. Manunga, MD Location: Grand Ballroom West, 3rd Floor
2:14 PM - 2:19 PM	RCTs And Meta-Analyses Can Be Flawed And Biased: They Should Only Be Viewed With Other Evidence And Common Sense
	Presenter(s):George S. Lavenson, MD Location: Grand Ballroom West, 3rd Floor
2:20 PM - 2:25 PM	Why Systematic Reviews And Meta-Analyses Can Be Misleading: What To Do About It
	Presenter(s):Janet T. Powell, MD, PhD Location: Grand Ballroom West, 3rd Floor
ISSUES IN VASCULAR TRAINING
2:26 PM - 2:31 PM	Coming Crisis In Vascular Surgical Training – In Both 5+2 And 0+5 Programs: What Can Be Done About It
	Presenter(s):Michael B. Silva, Jr., MD Location: Grand Ballroom West, 3rd Floor
2:32 PM - 2:37 PM	How To Remedy The Deficiency Vascular Fellows And Residents Have In Numbers Of Open Vascular Surgical Operations
	Presenter(s):Malachi Sheahan, MD Location: Grand Ballroom West, 3rd Floor
2:38 PM - 2:43 PM	Ten Golden Rules To Train Vascular Surgeons In Distal Bypass Procedures In 2020
	Presenter(s):Francesco Spinelli, MD Location: Grand Ballroom West, 3rd Floor
2:44 PM - 2:49 PM	Ten Top Tips For Establishing An Independent Research Initiative In Vascular Surgery After Training
	Presenter(s):Philip P. Goodney, MD, MS Location: Grand Ballroom West, 3rd Floor
2:50 PM - 2:58 PM	Panel Discussion And Break Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 36

SESSION 37 SCHEDULE
Wednesday SESSION 37: MORE ISSUE RELATED TOPICS IMPORTANT TO VASCULAR SURGEONS AND VASCULAR SPECIALISTS; ISSUES RELATED TO OUTPATIENT CENTERS OR OFFICE BASED LABS (OBLs) Location: Grand Ballroom West, 3rd Floor Moderators:Peter Gloviczki, MD / Enrico Ascher, MD
x
2:58 PM - 3:03 PM	Heart And Vascular Centers Are Artificial Entities That Disadvantage Vascular Surgeons
	Presenter(s):Malachi Sheahan, MD Location: Grand Ballroom West, 3rd Floor
3:04 PM - 3:09 PM	The Wellness Of Vascular Surgeons: Physical And Mental: How To Monitor It And How To Promote It And Prevent Burnout
	Presenter(s):Samuel R. Money, MD, MBA Location: Grand Ballroom West, 3rd Floor
3:10 PM - 3:15 PM	Unfilled Promises With Devices, Drugs And Treatments: Initial Hype That Is Not Fulfilled: It Is Often Hidden: More Transparency Is Needed: A Few Examples
	Presenter(s):Sherif A.H. Sultan, MD, FRCS, EBQS-VASC Location: Grand Ballroom West, 3rd Floor
3:16 PM - 3:21 PM	Advances In Telecare For Vascular Surgeons: What Is The Best Technology: What Does The Future Hold And What Was The Impact Of The COVID-19 Shutdowns
	Presenter(s):John (Jeb) W. Hallett, MD Location: Grand Ballroom West, 3rd Floor
3:22 PM - 3:27 PM	How To Improve Operating Room Efficiency For Vascular Surgical Operations: Why It Is So Widespread And Hard To Fix
	Presenter(s):Panos Kougias, MD, MSc Location: Grand Ballroom West, 3rd Floor
3:28 PM - 3:33 PM	Why Is The Per Capita Use Of EVAR And TAVR Dramatically Higher In New York State, USA Than Ontario, Canada
	Presenter(s):Sean P. Roddy, MD / Robert M. Zwolak, MD, PhD Location: Grand Ballroom West, 3rd Floor
3:34 PM - 3:39 PM	How To Avoid Lawsuits In Vascular Surgery And Other Vascular Specialties
	Presenter(s):Russell H. Samson, MD, RVT, FACS Location: Grand Ballroom West, 3rd Floor
3:40 PM - 3:45 PM	Panel Discussion
ISSUES RELATED TO OUTPATIENT CENTERS AND OBLs
3:45 PM - 3:50 PM	Why And How Do Outpatient Angio Suites And OBLs Fail
	Presenter(s):Sam S. Ahn, MD, FACS, MBA Location: Grand Ballroom West, 3rd Floor
3:51 PM - 3:56 PM	Tips And Tricks For Performing High Risk Lower Extremity Endovascular Procedures Safely And Successfully In An Outpatient Setting
	Presenter(s):Anil P. Hingorani, MD / Enrico Ascher, MD Location: Grand Ballroom West, 3rd Floor
3:57 PM - 4:02 PM	A Balanced View Of Atherectomy In Outpatient Facilities And OBLs In 2020: Is The Procedure Overused And Why
	Presenter(s):Krishna Jain, MD Location: Grand Ballroom West, 3rd Floor
4:03 PM - 4:08 PM	Inherent Conflicts Of Interest In OBLs: Why They Occur And Are Bad For Patients: How To Counteract Them
	Presenter(s):O. William Brown, MD, JD Location: Grand Ballroom West, 3rd Floor
4:09 PM - 4:13 PM	Panel Discussion
END OF SESSION 37

SESSION 38 SCHEDULE
Wednesday SESSION 38: UPDATES AND ISSUES IMPORTANT TO ALL VASCULAR SURGEONS AND SPECIALISTS: FUTURE REIMBURSEMENT; ETHICS OF INSURANCE; VASCULAR REGISTRIES AND THE VQI, VALUE OF GUIDELINES, ENDPOINTS; INDUSTRY RELATIONS; IMPACT OF GOVERNMENT (ACA) AND REGULATORY AGENCIES (FDA) Location: Grand Ballroom West, 3rd Floor Moderators:Jack L. Cronenwett, MD / Robert M. Zwolak, MD, PhD
x
4:13 PM - 4:18 PM	What Obstacles And Blows Are Vascular Surgeons And Other Vascular Specialists Facing In 2021: Will Planned Increased Reimbursement For Office And Hospital Visits Cause Decreases In Procedural Reimbursements
	Presenter(s):Sean P. Roddy, MD Location: Grand Ballroom West, 3rd Floor
4:19 PM - 4:24 PM	How Can Vascular Surgeons Identify High Risk, High Cost Patients And Help Health Care Systems Control Costs: How To Prevent Inappropriate Treatments In These Patients
	Presenter(s):Lee Kirksey, MD Location: Grand Ballroom West, 3rd Floor
4:25 PM - 4:30 PM	Update On Valuable New Information From The International Consortium of Vascular Registries (ICVR)
	Presenter(s):Adam Beck, MD Location: Grand Ballroom West, 3rd Floor
4:31 PM - 4:36 PM	The Role And Value Of Guidelines In Vascular Practice; Why Guidelines Can Be Misleading; How Should They Be Written To Not Be
	Presenter(s):Anders Wanhainen, MD, PhD Location: Grand Ballroom West, 3rd Floor
4:37 PM - 4:42 PM	The Ethics Of The Health Insurance Business Models To Reduce Costs: Patients Are Not Being Well Served: What Can Be Done About It
	Presenter(s):James W. Jones, MD, PhD, MHA Location: Grand Ballroom West, 3rd Floor
4:43 PM - 4:48 PM	Importance Of Clinical Endpoints (Like Wound Healing, Amputation) Rather Than Proxy Endpoints (Like TLR) In Evaluating New Endovascular Technology And Its Incremental Benefits
	Presenter(s):Jim Reekers, MD, PhD Location: Grand Ballroom West, 3rd Floor
4:49 PM - 4:54 PM	Effects Of The Affordable Care Act (ACA) On Vascular Surgical Outcomes: Does The Medicaid Expansion Of The ACA Improve Outcomes Or Not
	Presenter(s):Mohammad H. Eslami, MD, MPH Location: Grand Ballroom West, 3rd Floor
4:55 PM - 5:00 PM	Despite What The New York Times And Others Say, Close Relationships Of Vascular Surgeons With Industry Are Ethical And Beneficial To Patients And Society: Pitfalls To Avoid
	Presenter(s):Bruce A. Perler, MD, MBA Location: Grand Ballroom West, 3rd Floor
5:01 PM - 5:06 PM	Panel Discussion
5:06 PM - 5:11 PM	Propensity Score Matching Studies: How Do They Work And What Are Their Strengths And Weaknesses
	Presenter(s):Charles C. Miller, PhD Location: Grand Ballroom West, 3rd Floor
REGULALTORY ISSUES
5:12 PM - 5:17 PM	Historical Perspective Over The Last 25 Years On FDA Approvals Of EVAR Devices Submitted By Investigators And Industry: Lessons Learned To Guide Future Applications
	Presenter(s):Dorothy B. Abel, BSBME Location: Grand Ballroom West, 3rd Floor
5:18 PM - 5:23 PM	The New (2020) European Regulations For Medical Device Approval: Will They Impede Approval Of Endovascular Treatments
	Presenter(s):Jim Reekers, MD, PhD Location: Grand Ballroom West, 3rd Floor
5:24 PM - 5:29 PM	Are The Quality, Safety And Effectiveness Of Generic Drugs Equating Those Of The Patented Original Drugs: How Is The FDA Assuring Equivalence; Should The FDA Do More
	Presenter(s):Valerie M. Merkle, PhD Location: Grand Ballroom West, 3rd Floor
JOURNAL ISSUES
5:30 PM - 5:35 PM	How To Get A Paper Accepted In A High Impact Journal Like The JVS: Does Bias Ever Matter
	Presenter(s):Peter Gloviczki, MD Location: Grand Ballroom West, 3rd Floor
5:36 PM - 5:41 PM	Non-Compliance With The SVS AAA Practice Guidelines Is Common: How Does It Impact On Outcomes
	Presenter(s):Elliot L. Chaikof, MD, PhD Location: Grand Ballroom West, 3rd Floor
VQI TOPICS
5:42 PM - 5:47 PM	Recent Challenges And Accomplishments Of The SVS VQI: A Worthy Organization
	Presenter(s):Jens Eldrup-Jorgensen, MD / Jack L. Cronenwett, MD Location: Grand Ballroom West, 3rd Floor
5:48 PM - 5:53 PM	Using The SVS VQI To Improve The Practice Of Vascular Surgery: What Is The Concept Of CAPT And How Can It Help
	Presenter(s):Fred A. Weaver, MD, MMM Location: Grand Ballroom West, 3rd Floor
5:54 PM - 6:00 PM	Panel Discussion End of Program E
END OF SESSION 38

SESSION 39 SCHEDULE
Wednesday SESSION 39: MORE TOPICS RELATED TO THE THORACIC AORTA, AORTIC DISSECTIONS, INTRAMURAL HEMATOMAS (IMHs), PENETRATING AORTIC ULCERS (PAU) AND THEIR TREATMENT Location: Trianon Ballroom, 3rd Floor Moderators:Ramon Berguer, MD, PhD / ShenMing Wang, MD, PhD / Paulo E. Ocke Reis, MD, PhD
x
6:50 AM - 6:55 AM	Aortic Arch Type And Adequacy Of The Proximal Seal Zone Are Important Determinants Of TEVAR Outcomes In Treatment Of TBADs
	Presenter(s):Firas F. Mussa, MD Location: Trianon Ballroom, 3rd Floor
6:56 AM - 7:01 AM	False Lumen Area >50% Of Total Aortic Cross-Section Area At The Tracheal Bifurcation At Time Of TEVAR For TBAD Is A Predictor Of Early Death: How To Decrease This Mortality
	Presenter(s):Johnny Steuer, MD, PhD Location: Trianon Ballroom, 3rd Floor
7:02 AM - 7:07 AM	Value Of Stent-Grafts In Genetically Triggered Aortopathy
	Presenter(s):Cherrie Z. Abraham, MD Location: Trianon Ballroom, 3rd Floor
7:08 AM - 7:13 AM	How Best To Deal With A Persistent Or Enlarging False Lumen After TEVAR For TBAD
	Presenter(s):Nicola Mangialardi, MD Location: Trianon Ballroom, 3rd Floor
7:14 AM - 7:19 AM	Update On Use And Value Of The Candy Plug Endovascular Device To Treat Chronic TBADs With A TAAA
	Presenter(s):Tilo Koelbel, MD, PhD Location: Trianon Ballroom, 3rd Floor
7:20 AM - 7:25 AM	Panel Discussion
7:25 AM - 7:30 AM	Staged Hybrid Single Lumen Reconstruction Is The Best Treatment For Complex Chronic TBAD With Visceral Segment Involvement Of The Aorta: How To Do It, Advantages And Results
	Presenter(s):Sherif A.H. Sultan, MD, FRCS, EBQS-VASC Location: Trianon Ballroom, 3rd Floor
7:31 AM - 7:36 AM	Reinterventions After TEVAR For TBADs: How To Decrease Them At The Index Procedure And How Planning Helps
	Presenter(s):Bijan Modarai, PhD, FRCS Location: Trianon Ballroom, 3rd Floor
7:37 AM - 7:42 AM	Adjunctive Peripheral And Visceral Interventions During TEVAR For Complicated TBADs: Indications, Technical Tips And Results
	Presenter(s):Mark K. Eskandari, MD Location: Trianon Ballroom, 3rd Floor
7:43 AM - 7:48 AM	Update On Intramural Hematoma (IMH): Etiology, Natural History And Indications For TEVAR
	Presenter(s):Frank J. Criado, MD Location: Trianon Ballroom, 3rd Floor
7:49 AM - 7:54 AM	Natural History And Optimal Treatment For Penetrating Aortic Ulcers (PAUs) When To Observe And When To Treat With TEVAR
	Presenter(s):Colin D. Bicknell, MD, FRCS Location: Trianon Ballroom, 3rd Floor
7:55 AM - 8:00 AM	Panel Discussion
END OF SESSION 39

SESSION 40 SCHEDULE
Wednesday SESSION 40: MORE ADVANCES RELATED TO SESSIONS INVOLVING THE ASCENDING AORTA AND THE AORTIC ARCH; AORTIC DISSECTIONS AND THEIR TREATMENT Location: Trianon Ballroom, 3rd Floor Moderators:Rodney A. White, MD / Joseph E. Bavaria, MD
x
8:00 AM - 8:05 AM	Value Of Transcranial Doppler (TCD) For TEVAR And Endo Procedures Involving The Ascending Aorta And Aortic Arch
	Presenter(s):Alan B. Lumsden, MD, FACS Location: Trianon Ballroom, 3rd Floor
8:06 AM - 8:11 AM	Antegrade Stent-Graft Delivery For Treating Acute Type A Dissections: When Is It Advantageous And How To Do It
	Presenter(s):Ourania Preventza, MD / Joseph S. Coselli, MD Location: Trianon Ballroom, 3rd Floor
8:12 AM - 8:17 AM	Role Of Bare Metal Stents (Ascyrus Medical) For Repair Of Acute Type A Dissections: Indications And Results
	Presenter(s):Grayson H. Wheatley, MD Location: Trianon Ballroom, 3rd Floor
8:18 AM - 8:23 AM	Caval Balloon Occlusion: A Better Way Than Rapid Pacing To Permit Precise Stent-Graft Placement In The Proximal Aorta: How To Do It And Is It Better For The Heart
	Presenter(s):Bjõrn Sonesson, MD, PhD Location: Trianon Ballroom, 3rd Floor
8:24 AM - 8:29 AM	For Precise TEVAR In The Aortic Arch Rapid Pacing And Caval Occlusion Are NOT Needed: Valsalva And PEEP By Anesthesiologist Do Just As Well And Are Simple: Technical Tips
	Presenter(s):Nikolaos Tsilimparis, MD; PhD Location: Trianon Ballroom, 3rd Floor
8:30 AM - 8:35 AM	Panel Discussion
8:35 AM - 8:40 AM	Arch Lesion Repair With Single, Double Or 3-Branched Devices: When Is Each Best And Why
	Presenter(s):Gustavo S. Oderich, MD, FACS Location: Trianon Ballroom, 3rd Floor
8:41 AM - 8:46 AM	Chimney Technique For Dealing With Total Arch Lesions And Dissections: How To Make It Work, Limitations And Results
	Presenter(s):Ivo Petrov, MD, PhD Location: Trianon Ballroom, 3rd Floor
8:47 AM - 8:52 AM	Laser Fenestration Option For TEVAR Involving The Great Arch Branches: When Is It Better Than Branched Endografts: Technique And Results
	Presenter(s):Timothy A. Resch, MD, PhD Location: Trianon Ballroom, 3rd Floor
8:53 AM - 8:58 AM	For Aortic Arch Repairs In Situ Fenestration Is Superior To Chimney TEVAR: New Technology From Life Tech For Doing It
	Presenter(s):Ralf R. Kolvenbach, MD Location: Trianon Ballroom, 3rd Floor
8:59 AM - 9:04 AM	For Distal Aortic Arch Pathology Custom Fenestrated Grafts (From Cook) Are The Best Repair Technique: Why
	Presenter(s):Nikolaos Tsilimparis, MD; PhD Location: Trianon Ballroom, 3rd Floor
9:05 AM - 9:11 AM	Panel Discussion
9:11 AM - 9:24 AM	Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 40

SESSION 41 SCHEDULE
Wednesday SESSION 41: OPEN AND ENDO TREATMENT OF COMPLEX AAAs (JUXTA, PARA- AND SUPRA-RENAL) AND TAAAs; NEW DEVICES FOR THEIR TREATMENT Location: Trianon Ballroom, 3rd Floor Moderators:Giovanni B. Torsello, MD / Gustavo S. Oderich, MD, FACS
x
COMPLEX AAAs AND TAAAs
9:24 AM - 9:29 AM	Open Repair Is The Best Way To Treat Short Neck, No Neck And Pararenal AAAs: Why Is This So
	Presenter(s):Laurent Chiche, MD, FEBVS Location: Trianon Ballroom, 3rd Floor
9:30 AM - 9:35 AM	Long-Term Survival Results After Type II TAAA Endovascular Repair: When Is The Procedure Contraindicated
	Presenter(s):Matthew J. Eagleton, MD Location: Trianon Ballroom, 3rd Floor
9:36 AM - 9:41 AM	How To Make 3 Chimney EVAR With Involvement Of The SMA Safe And Effective
	Presenter(s):Konstantinos P. Donas, MD Location: Trianon Ballroom, 3rd Floor
9:42 AM - 9:47 AM	Value Of Ch/EVAR For Juxtarenal AAAs: They Are As Safe And Effective As Any Other Procedure And Simpler
	Presenter(s):Joost A. van Herwaarden, MD, PhD Location: Trianon Ballroom, 3rd Floor
9:48 AM - 9:53 AM	Advances In Endovascular TAAA Repair In Canada: Making The Procedure Safe And Diagnosing And Fixing Late Type 3 Endoleaks
	Presenter(s):Thomas F. Lindsay, MDCM, FRCS, FACS Location: Trianon Ballroom, 3rd Floor
9:54 AM - 9:59 AM	Comparison Of Endo And Open Repair Of Post Dissection TAAAs: Which Procedure Is Best And When
	Presenter(s):Fabio Verzini, MD, PhD Location: Trianon Ballroom, 3rd Floor
10:00 AM - 10:05 AM	Comparative Morbidity And Mortality Outcomes Of Open, Hybrid And F/B/EVAR For Type II And III TAAAs Justify Greater Use Of F/B/EVAR For These Complex Lesions
	Presenter(s):Gilbert R. Upchurch, MD / Dean Arnaoutakis, MD / Salvatore T. Scali, MD Location: Trianon Ballroom, 3rd Floor
10:06 AM - 10:12 AM	Panel Discussion
TOPICS RELATED TO INTERESTING NEW DEVICES
10:12 AM - 10:17 AM	A New Hybrid Device (Thoracoflo From Terumo Aortic) For TAAA Repair: How It Works, Early Clinical Experience And Advantages
	Presenter(s):Sebastian E. Debus, MD, PhD Location: Trianon Ballroom, 3rd Floor
10:18 AM - 10:23 AM	How To Prevent Patch Aneurysms After Open TAAA Repair With Long Antegrade Grafts: How To Treat Them When They Occur
	Presenter(s):Thomas C. Bower, MD / Manju Kalra, MBBS Location: Trianon Ballroom, 3rd Floor
10:24 AM - 10:29 AM	Why AAA Sac Shrinkage Is Better After EVAR With The Treo (From Terumo Aortic) Endograft
	Presenter(s):Michael C. Stoner, MD Location: Trianon Ballroom, 3rd Floor
10:30 AM - 10:35 AM	Update On The Colt Manifold Device For TAAAs, Complex AAAs, Failed EVARs And Failed EVAS Procedures: How Does It Work And Results
	Presenter(s):Piotr Szopinski, MD, PhD Location: Trianon Ballroom, 3rd Floor
10:36 AM - 10:41 AM	We Flow Device For Juxtarenal AAA Repair: A New Approach: How Does It Work And Early Results
	Presenter(s):Wei Guo, MD Location: Trianon Ballroom, 3rd Floor
10:42 AM - 10:48 AM	Panel Discussion
END OF SESSION 41

SESSION 42 SCHEDULE
Wednesday SESSION 42: PROGRESS IN TREATING ILIAC ANEURYSMS; ILIAC BRANCHED DEVICES (IBDs); UPDATE ON MULTILAYER FLOW MODULATING (MLFM) AND OTHER BARE STENTS FOR TREATING ANEURYSMS AND DISSECTIONS Location: Trianon Ballroom, 3rd Floor Moderators:Thomas S. Maldonado, MD / Nicholas J.W. Cheshire, MD
x
TREATMENT OF ILIAC ANEURYSMS AND IBDs
10:48 AM - 10:53 AM	DEBATE: How Best To Treat Iliac Aneurysms In 2020: There Is Not Much Of A Need For Open Surgery
	Presenter(s):Stefan Müller-Hülsbeck, MD Location: Trianon Ballroom, 3rd Floor
10:54 AM - 10:59 AM	DEBATE: There Is A Role For Open Surgery In The Treatment Of Iliac Aneurysms: What Is It And Technical Tips
	Presenter(s):Heron E. Rodriguez, MD Location: Trianon Ballroom, 3rd Floor
11:00 AM - 11:05 AM	Long-Term Experience With Cook IBD For The Treatment Of Common Iliac Aneurysms: Advantages And Limitations
	Presenter(s):Giovanni B. Torsello, MD Location: Trianon Ballroom, 3rd Floor
11:06 AM - 11:11 AM	Terumo Aortic Customized Iliac Branched Device: How Is It Different From Other IBDs: Advantages And Limitations
	Presenter(s):Afshin Assadian, MD Location: Trianon Ballroom, 3rd Floor
11:12 AM - 11:17 AM	Update On The Gore IBE Excluder For Treating Iliac Aneurysms And Preserving Hypogastric Artery Flow: Advantages And Limitations: From The European ICEBERG Registry
	Presenter(s):Michel M.P. Reijnen, MD, PhD Location: Trianon Ballroom, 3rd Floor
11:18 AM - 11:23 AM	Long-Term Comparison Of The Cook Zenith And Gore Excluder IBDs: Advantages And Limitations Of Both
	Presenter(s):Giovanni Pratesi, MD Location: Trianon Ballroom, 3rd Floor
11:24 AM - 11:30 AM	Panel Discussion
UPDATE ON MULTILAYER FLOW MODULATING (MLFM) BARE STENTS
11:30 AM - 11:35 AM	Why MLFM Bare Stents Should Be The Treatment Of Choice For Visceral, Peripheral And Iliac Aneurysms: Advantages And Has Rupture Been Universally Prevented
	Presenter(s):Michel C. Henry, MD Location: Trianon Ballroom, 3rd Floor
11:36 AM - 11:41 AM	MLFM Bare Stent (From Cardiatis) Is A Promising Treatment For Acute Aortic Dissections: What Is the Evidence In Support
	Presenter(s):Rodney A. White, MD Location: Trianon Ballroom, 3rd Floor
11:42 AM - 11:47 AM	Improved Outcomes Of Type A Aortic Dissections With Use Of Bare Stents (Cardiatis And Ascyrus): They Decrease Malperfusion, Promote Aortic Remodeling And Prevent Strokes: How Do They Work
	Presenter(s):Ralf R. Kolvenbach, MD Location: Trianon Ballroom, 3rd Floor
11:48 AM - 11:53 AM	Update On The Long-Term Results Of The MLFM Bare Stents (Cardiatis) In The Treatment Of TAAAs: Are They Proving Safe And Effective Mid And Long-Term: What Is Their Role
	Presenter(s):Claude D. Vaislic, MD Location: Trianon Ballroom, 3rd Floor
11:54 AM - 12:00 PM	Panel Discussion
12:00 PM - 1:00 PM	Lunch Break -2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 42

SESSION 43 SCHEDULE
Wednesday SESSION 43: MORE NEW DEVELOPMENTS IN AAA TREATMENT AND STANDARD EVAR: A NEW DEVICE TO SLOW AAA GROWTH; AAA NECK DILATATION AFTER EVAR; VALUE OF LOW PROFILE AAA ENDOGRAFTS; LINK TO CANCER; IMPROVED ULTRASOUND SURVEILLANCE AND ALL AAAs ARE NOT TIME BOMBS WAITING TO EXPLODE Location: Trianon Ballroom, 3rd Floor Moderators:Juan C. Parodi, MD / Claude Mialhe, MD
x
1:00 PM - 1:05 PM	A Novel New Technology (Nectero) To Slow AAA Growth; How Does It Work And Early Clinical Results
	Presenter(s):Venkatesh G. Ramaiah, MD Location: Trianon Ballroom, 3rd Floor
AAA NECK BEHAVIOR AFTER EVAR
1:06 PM - 1:11 PM	Impact Of Oversizing And Level Of Fixation (Infra Versus Supra-Renal) On Aortic Neck Behavior: How Do These Variables Affect EVAR Outcomes: From A 10-Year Study
	Presenter(s):Carlos F. Bechara, MD Location: Trianon Ballroom, 3rd Floor
1:12 PM - 1:17 PM	Aortic Neck Dilatation Is Different After F/EVAR And EVAR: What Is The Reason And Why Is It Important For Outcomes
	Presenter(s):Thomas S. Maldonado, MD Location: Trianon Ballroom, 3rd Floor
1:18 PM - 1:23 PM	Major Aortic Neck Dilatation Occurs Equally After EVAR And Open Repair: From The DREAN RCT: This ONLY Occurs After EVAR With Self-Expanding Endografts
	Presenter(s):Jan D. Blankensteijn, MD Location: Trianon Ballroom, 3rd Floor
1:24 PM - 1:29 PM	Do AAA Necks Dilate After F/EVAR For Juxtarenal AAAs: What Are The Good Or Bad Consequences For Procedural Outcomes
	Presenter(s):Benjamin W. Starnes, MD Location: Trianon Ballroom, 3rd Floor
1:30 PM - 1:35 PM	DEBATE: Low Profile Devices For EVAR Are Failing: Their Future Is Questionable
	Presenter(s):Hence J.M. Verhagen, MD, PhD Location: Trianon Ballroom, 3rd Floor
1:36 PM - 1:41 PM	DEBATE: Not So: Ovation Stent-Graft (From Endologix) Have Good 5-Year Results With No Neck Dilatation Or Migration Even With Challenging Neck Anatomy: Based On A Multicenter International Study Of A Low Profile Endograft
	Presenter(s):Mahmoud B. Malas, MD, MHS Location: Trianon Ballroom, 3rd Floor
1:42 PM - 1:47 PM	Current Status Of The Link Between EVAR And Cancer: Is It Real And What Is Its Etiology
	Presenter(s):Janet T. Powell, MD, PhD Location: Trianon Ballroom, 3rd Floor
1:48 PM - 1:53 PM	Why 3D Ultrasound Should Replace CTA For AAA Post EVAR Surveillance And Other Purposes: Advantages And Limitations
	Presenter(s):Henrik Sillesen, MD, DMSc Location: Trianon Ballroom, 3rd Floor
1:54 PM - 1:59 PM	Presenting AAAs As Ticking Time Bombs Or Unexploded Grenades Is Wrong-Headed, Inaccurate And Harmful
	Presenter(s):Frank J. Criado, MD Location: Trianon Ballroom, 3rd Floor
2:00 PM - 2:06 PM	Panel Discussion
END OF SESSION 43

SESSION 44 SCHEDULE
Wednesday SESSION 44: MORE NEW DEVELOPMENTS IN AAAs: HOW DO THEIR NECK AND SAC SIZE AND THROMBUS LOAD EFFECT PROGNOSIS AFTER EVAR AND EVAS; OTHER RELATED AAA TOPICS Location: Trianon Ballroom, 3rd Floor Moderators:Ali F. AbuRahma, MD / Janet T. Powell, MD, PhD
x
AAA NECK AND SAC THROMBUS LOAD
2:06 PM - 2:11 PM	Impact Of Thrombus In AAA Sac And Neck On AAA Behavior And EVAR Outcomes: How To Quantitate Thrombus Load And Distribution
	Presenter(s):Nicos Labropoulos, BSc (Med), PhD, DIC, RVT Location: Trianon Ballroom, 3rd Floor
2:12 PM - 2:17 PM	DEBATE: Large Amount Of AAA Sac Thrombus Promotes Morbidity Without Rupture And Rupture: What Is The Mechanism And How To Quantitate Thrombus Load
	Presenter(s):David H. Deaton, MD, FACS Location: Trianon Ballroom, 3rd Floor
2:18 PM - 2:23 PM	DEBATE: Large Flow Lumenal Space In AAA Sac With Minimal Mural Thrombus Is Associated With Adverse Events After EVAR: It Is More Important Than AAA Sac Size: Thrombus May Be Protective
	Presenter(s):Hence J.M. Verhagen, MD, PhD Location: Trianon Ballroom, 3rd Floor
2:24 PM - 2:29 PM	Graft Infolding: A Unique EVAR Complication: How To Prevent It and How To Treat It
	Presenter(s):Ashraf Mansour, MD Location: Trianon Ballroom, 3rd Floor
2:30 PM - 2:35 PM	Large AAA Necks (> 29 mm) Increase Migration And Leak Risks After EVAR With Self-Expanding Endografts Due To Neck Dilatation: Not So With Anatomically Adaptive (Polymer) Sealing Endografts (Ovation) Which Are Not Followed With Neck Dilatation
	Presenter(s):Hence J.M. Verhagen, MD, PhD Location: Trianon Ballroom, 3rd Floor
2:36 PM - 2:41 PM	Does Doxycycline Stabilize AAA Neck Diameter: From The NTACT Trial
	Presenter(s):Jon S. Matsumura, MD Location: Trianon Ballroom, 3rd Floor
2:42 PM - 2:47 PM	EVAS With Sac Filling Technology (Nellix) Has Lower Late Mortality Than EVAR With Other Endografts – Especially With Large AAAs: What Is The Mechanism Thought To Be
	Presenter(s):Marc L. Schermerhorn, MD Location: Trianon Ballroom, 3rd Floor
2:48 PM - 2:53 PM	Technical Tips To Perform SAFE Large Sheath Percutaneous Femoral Access For Complex AAA EVAR In Obese Or Scarred Groins – Even With Calcified Arteries
	Presenter(s):Barend M.E. Mees, MD, PhD Location: Trianon Ballroom, 3rd Floor
2:54 PM - 2:59 PM	4X Increased 18F FDG Uptake On PET CT In Female AAA Patients Compared To Males Indicates Increased Aortic Wall Inflammation: Does This Explain Increased Rupture Risk In Females: Implications For Treatment
	Presenter(s):Natzi Sakalihasan, MD, PhD Location: Trianon Ballroom, 3rd Floor
3:00 PM - 3:06 PM	Panel Discussion
3:06 PM - 3:15 PM	Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 44

SESSION 45 SCHEDULE
Wednesday SESSION 45: SHORT HOT AORTIC TOPICS (4 ¾-MINUTE FAST PACED TALKS) Location: Trianon Ballroom, 3rd Floor Moderators:Timothy A.M. Chuter, DM / Luis A. Sanchez, MD
x
3:15 PM - 3:20 PM	Large Diameter AAAs Negatively Impacts Patient Survival After EVAR: Is Inflammation Involved And What Can Be Done About It
	Presenter(s):Matt M. Thompson, MD Location: Trianon Ballroom, 3rd Floor
3:20 PM - 3:25 PM	A Large Proportion Of EVARs Are Performed On Small AAAs: What Are The Implications And What Should Be Done About It
	Presenter(s):Salvatore T. Scali, MD Location: Trianon Ballroom, 3rd Floor
3:25 PM - 3:30 PM	Late Delayed Renal Artery Revascularization After Inadvertent Occlusion During Complex EVAR Is Worthwhile: Collaterals Keep The Kidney Viable Although No Urine Is Produced
	Presenter(s):Nikolaos Tsilimparis, MD; PhD Location: Trianon Ballroom, 3rd Floor
3:30 PM - 3:35 PM	Global Trends In AAA Mortality: What Reasons Explain These Trends
	Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh, F Location: Trianon Ballroom, 3rd Floor
3:35 PM - 3:40 PM	How Can A Long-Term Aortic Risk (LEAR) Model Predict Mortality And Complication Risks And Guide Surveillance: Can The Model Be Made Device Specific
	Presenter(s):Pete Holt, MD, PhD Location: Trianon Ballroom, 3rd Floor
3:40 PM - 3:45 PM	Update On Status Of Retrograde And Prograde In Situ Fenestration For Arch Aneurysms And TAAAs: How To Do Them
	Presenter(s):Jean M. Panneton, MD Location: Trianon Ballroom, 3rd Floor
3:45 PM - 3:50 PM	Long-Term Propensity Matched Comparison Of Open Repair And F/B/EVAR For Pararenal And Paravisceral AAAs
	Presenter(s):Giovanni G.T. Tinelli, MD, PhD Location: Trianon Ballroom, 3rd Floor
3:50 PM - 3:55 PM	Panel Discussion
3:55 PM - 4:00 PM	Safe Anticoagulation In F/B/EVAR Patients Requiring Spinal Fluid Drainage
	Presenter(s):Afshin Assadian, MD Location: Trianon Ballroom, 3rd Floor
4:00 PM - 4:05 PM	Visceral Debranching With A Simple Aortic Endograft Is The Best Way To Treat TAAAs In Good Risk Patients: How To Do It Safely
	Presenter(s):Guillermo A. Escobar, MD Location: Trianon Ballroom, 3rd Floor
4:05 PM - 4:10 PM	Update On Maintaining Euglycemia To Decrease Spinal Cord Ischemia With Complex AAA And TAAA Repairs
	Presenter(s):Jade S. Hiramoto, MD Location: Trianon Ballroom, 3rd Floor
4:10 PM - 4:15 PM	Incidence And Etiology Of Cerebrovascular Injuries With Acute TBADs With And Without Treatment
	Presenter(s):Loay S. Kabbani, MD, MHSA Location: Trianon Ballroom, 3rd Floor
4:15 PM - 4:20 PM	EVAR, F/EVAR And B/EVAR Results In Females: Are There Still Differences
	Presenter(s):Athanasios Katsargyris, MD / Eric L.G. Verhoeven, MD, PhD Location: Trianon Ballroom, 3rd Floor
4:20 PM - 4:25 PM	Update On Performing EVAR With Only IVUS Guidance To Decrease Radiation: Technical Tips And 3-Year Results
	Presenter(s):Jörg Tessarek, MD Location: Trianon Ballroom, 3rd Floor
4:25 PM - 4:30 PM	Risk Factors And Late Clinical Consequences Of AAA Neck Dilatation >6 Years After EVAR With Self-Expanding Endografts: Does The Neck Keep Dilating After The Spring Is Gone: What Are The Differences Between Excluder And Endurant Endografts
	Presenter(s):Hence J.M. Verhagen, MD, PhD Location: Trianon Ballroom, 3rd Floor
4:30 PM - 4:35 PM	Panel Discussion
END OF SESSION 45

SESSION 46 SCHEDULE
Wednesday SESSION 46: MORE SHORT HOT NEW TOPICS RELATED TO AORTIC DISEASE AND ITS TREATMENT (4 ¾-MINUTE FAST PACED TALKS) Location: Trianon Ballroom, 3rd Floor Moderators:Fred A. Weaver, MD, MMM / Michael L. Marin, MD
x
4:35 PM - 4:40 PM	Role Of Endovascular And Open Treatment For Mid Aortic Syndrome In Children, Teenagers And Young Adults
	Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS Location: Trianon Ballroom, 3rd Floor
4:40 PM - 4:45 PM	Endovascular Repair Of Thoracic Aneurysms With TEVAR Outside IFUs: Value And Limitations: From A Multicenter Study
	Presenter(s):Fabio Verzini, MD, PhD Location: Trianon Ballroom, 3rd Floor
4:45 PM - 4:50 PM	A New Gene Family In AAA Smooth Muscle Is Related To Aneurysm Diameter And Rupture: Could It Be A Screening Tool
	Presenter(s):Kak Khee Yeung, MD, PhD Location: Trianon Ballroom, 3rd Floor
4:50 PM - 4:55 PM	Impact Of Iliac Aneurysms On The Treatment Of Complex AAAs
	Presenter(s):Matthew J. Eagleton, MD Location: Trianon Ballroom, 3rd Floor
4:55 PM - 5:00 PM	How To Make Ch/EVAR Work: A Standard Protocol Helps: What Are The Best Endografts For The Aorta; For The Branches: How To Prevent Gutter Endoleaks
	Presenter(s):Konstantinos P. Donas, MD Location: Trianon Ballroom, 3rd Floor
5:00 PM - 5:05 PM	How To Treat AAAs With Large (>34 mm Diameter) Necks: When EVAR; When F/EVAR; When Open
	Presenter(s):Rabih A. Chaer, MD Location: Trianon Ballroom, 3rd Floor
5:05 PM - 5:10 PM	3-Stage Concept For Treating Mega-Aortic Syndrome: Frozen Elephant Trunk (FET), TEVAR, Distal Open Repair: Results
	Presenter(s):Martin Czerny, MD Location: Trianon Ballroom, 3rd Floor
5:10 PM - 5:15 PM	Panel Discussion
5:15 PM - 5:20 PM	How Should Intramural Hematomas (IMHs) In The Ascending Aorta And Arch Be Treated
	Presenter(s):Jennifer L. Perri, MD, MBA / Timothy A.M. Chuter, DM Location: Trianon Ballroom, 3rd Floor
5:20 PM - 5:25 PM	How To Set Up A Large Multispecialty Acute Aortic Disease Network: How Does It Improve Results
	Presenter(s):Jean-Marc Alsac, MD, PhD Location: Trianon Ballroom, 3rd Floor
5:25 PM - 5:30 PM	How To Safely Stent The Large Fenestration Of A ZFEN Endograft When It Is Crossed By Struts: Indications For Doing So And Late Results
	Presenter(s):Luis A. Sanchez, MD Location: Trianon Ballroom, 3rd Floor
5:30 PM - 5:35 PM	An Unrecognized Mechanism For Causing Aortic Dissections: Shock Wave Energy Rather Than Increased Arterial Pressure Causes The Tear: How Does It Work And How To Decrease The Risk
	Presenter(s):Erno Remsey-Semmelweis, MD Location: Trianon Ballroom, 3rd Floor
5:35 PM - 5:40 PM	Are Low Profile Devices For EVAR And TEVAR Improving Or Worsening Outcomes
	Presenter(s):Naoki Fujimura, MD, PhD Location: Trianon Ballroom, 3rd Floor
5:40 PM - 5:45 PM	The Sandwich-Periscope Technique For Left Subclavian Revascularization With Zone 2 TEVAR: It May Be The Best Way And How To Do It
	Presenter(s):Sukgu Han, MD Location: Trianon Ballroom, 3rd Floor
5:45 PM - 5:50 PM	Comparison Of Endo And Open (Carotid-Subclavian Bypass) Treatments For Subclavian Artery Stenosis And Occlusions: Safety, Durability And Costs
	Presenter(s):Ali F. AbuRahma, MD Location: Trianon Ballroom, 3rd Floor
5:50 PM - 5:55 PM	Panel Discussion End of Program F
END OF SESSION 46